24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BioGenCell
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:48
Check Point unveils massive Tel Aviv campus as part of long-term cybersecurity expansion
17:52
Keyfactor acquires InfoSec Global as Merlin Ventures notches strategic exit
17:24
Full list of Israeli high-tech layoffs in 2025
17:22
AI startup Noogata shuts down after raising $28 million
More stories
Buzz
Most popular
Daily
Weekly
1
“You could argue that our share price should be a lot lower”: Intel tries to sell the vision while delivering losses
2
IBM’s Red Hat acquires stealth Israeli startup Jounce for $20M to bolster AI cloud stack
3
AI startup Noogata shuts down after raising $28 million
4
The 50 most promising Israeli startups - 2025
5
Nebius to build Israel’s AI supercomputer
More news
BioGenCell
1 stories about BioGenCell
BioGenCell pioneers revolutionary cell therapy for microvascular disease
11.07.24
|
Ariela Karmel
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation
